Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 977 of 2925 articles.
Rockefeller University Press launches new science journal with the publishing arms of EMBO and Cold Spring Harbor Laboratory
Life Science Alliance is an open-access, peer-reviewed journal with a streamlined manuscript submission and review process.
David Rockefeller Fellowship awarded to graduate student Krithika Venkataraman
Venkataraman has been recognized for her study of the hormonal triggers that lead female mosquitoes to toggle between hunting for blood and spawning eggs.
Bacterial art, sheep brains, and a fish race: highlights from our Science Saturday festival
The annual event invites children to campus for an unforgettable day of hands-on experiments and interactive learning.
30 young scientists receive Ph.D.s at Rockefeller’s 60th convocation
Since its first convocation, Rockefeller has granted doctor of philosophy degrees in bioscience to more than 1,260 students, including today’s graduates.
William E. Ford elected Chair of The Rockefeller University Board
Ford succeeds Russell L. Carson, who is retiring after leading the Board for the past 13 years.
Rockefeller tops global university ranking in measures of research excellence and patents
The university ranks first in two major categories in a survey of more than 1600 institutions.
A. James Hudspeth to receive Kavli Prize in Neuroscience
Hudspeth is receiving the honor for pioneering work on the molecular and neural mechanisms of hearing.
Sohail Tavazoie promoted to professor
Sohail Tavazoie, a physician-scientist who studies the genes that regulate a tumor’s ability to metastasize, has been promoted to professor.
Rockefeller takes first place in global ranking of scientific impact
Out of over 900 universities from 55 different countries, Rockefeller tops a survey measuring the impact of university research publications, scoring the highest percentage of frequently cited scientific publications.
Small molecule from Kapoor lab is accepted as first Bridge Medicines drug candidate
A chemical inhibitor targeting basal cell carcinoma, originating from Tarun Kapoor’s lab, is graduating from the Tri-Institutional Therapeutics Discovery Institute into Bridge Medicines.
View
View